Science

Beyond food: Bran-based gels show potential for targeted drug delivery

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 11/11/2026, 15:10:24 UTC.

Briefings

A Swedish study published in Biomacromolecules demonstrates that wheat and rye bran fibers can be engineered for direct drug delivery to treat colon diseases. The research indicates this approach could be effective for ulcerative colitis, Crohn's disease, and colorectal cancer, marking a potential shift from whole-grain foods to targeted medical applications.

Key points

• Researchers in Sweden developed a method to use wheat and rye bran fibers for direct drug delivery to the colon.
• The study was published in the journal Biomacromolecules, confirming the feasibility of this targeted delivery system for specific colorectal conditions.

Context

This research represents a significant advancement in colon health management, moving beyond dietary fiber to engineered therapeutic delivery systems for chronic diseases.

Limitations

The study is limited to the specific conditions mentioned (ulcerative colitis, Crohn's disease, colorectal cancer) and does not provide data on long-term efficacy, side effects, or scalability for broader clinical use.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 11/11/2026, 16:34:53 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeic6qqb4kkcrpxxtlum4fc625246dslzfwl4cnjsxj3evjebrkgdwa